AstraZeneca signs $18.5bn weight loss drug deal with CSPC
AstraZeneca has returned to CSPC with a licensing deal for the Chinese company’s monthly injectables for obesity.
IQVIA and Boehringer Ingelheim collaborate on therapeutic data transformation
AstraZeneca pours $15bn into Chinese R&D and manufacturing operations
Roche’s 2025 profit blunted by weakened US dollar
Eli Lilly outlays $1.12bn for hearing loss gene therapy partnership
The beginning of the end: Eliquis sales forecast to plummet as EU patent expiry nears
Analysis
View More
Themes
View MoreEli Lilly and NVIDIA to build pharma’s “most powerful” supercomputer
The partnership is the latest in a long line of AI-centric projects in drug discovery and development.
More themes
Data Insights
View MoreCell & gene therapy: the leading companies in recombinant AAV gene therapy revealed
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry
GlobalData Reports
View more
Digital Magazine
View MorePharma Technology Focus
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Huawei’s three key steps to drive industrial intelligence forward and unleash AI’s full potential
First responders see AI and other advanced tech as essential
What does the EU Data Act mean for businesses?
Trump blames Covid-19 drugmakers for fuelling CDC turmoil